One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

All news / April 2017

Archive

✕

10 April 2017

3970

Life4me+ Team Race on Nova Poshta Kyiv Half Marathon To Raise HIV Awareness

Life4me+ Team Race on Nova Poshta Kyiv Half Marathon To Raise HIV Awareness

The Life4me+ team members took part in the Nova Poshta Kyiv Half Marathon having run 21.4 km., devoting participation in the event to raising awareness about HIV and destigmatization of people living with HIV. The Life4me+ crew ran in branded T-shirts with an inspirational ...

7 April 2017

3445

Will Gilead's HIV Franchise Plan Be Broken On TrumpCare?

Will Gilead's HIV Franchise Plan Be Broken On TrumpCare?

On Thursday, Leerink analyst Geoffrey Porges outlined how Gilead's HIV drugs, including a combination of emtricitabine, bictegravir, and tenofovir alafenamide, could be at risk should The Republican Party, revive the American Health Care Act, or offer a similar alternative.

7 April 2017

3750

World Health Day 2017: The Theme Is 'Depression: Let's Talk'

World Health Day 2017: The Theme Is 'Depression: Let's Talk'

World Health Day 2017 will be celebrated today on April 7. Each year, the World Health Organisation (WHO) selects a theme highlighting a particular priority area of public health. The theme for this year's global health awareness day is 'Depression: Let's Talk.'

6 April 2017

3687

All Profits From The Life4me+ Mobile App Will Be Donated To Charity

All Profits From The Life4me+ Mobile App Will Be Donated To Charity

#Life4me+ is a unique mobile app, aimed to help HIV-positive people to live a full life. We wish our App to be maximally available for users around the world. It's obvious that paid content doesn’t allow many of our users to utilize all the application functions. That’s ...

6 April 2017

3758

Anti-Alcohol Program Could Make Fighting HIV Cheaper

Anti-Alcohol Program Could Make Fighting HIV Cheaper

Alcohol could be a factor in more than 13 percent of deaths from infectious diseases, including HIV. Specialists say drinking weakens the fight against the virus in two main ways: it makes transmission through risky sex more likely and undermines health by relaxing the rigour ...

6 April 2017

3431

France Reaches Agreement With Gilead To Drop Prices Of Hepatitis C Treatment

France Reaches Agreement With Gilead To Drop Prices Of Hepatitis C Treatment

The French Ministry of Social Affairs and Health announced recently that it has negotiated with Gilead pharmaceutical company to bring down the prices of hepatitis C medicines.

5 April 2017

4173

Should Every Breastfeeding Child Be Given PrEP If Mother Is HIV-Positive?

Should Every Breastfeeding Child Be Given PrEP If Mother Is HIV-Positive?

French researchers propose to give PrEP for all babies born from HIV-positive mothers in countries where the probability of transmission via breastfeeding remains significant. The study showed the effectiveness of using only one drug, lamivudine with the price of such therapy ...

4 April 2017

3609

AIDS Denialism in Russia: How This Destructive Influence Works?

AIDS Denialism in Russia: How This Destructive Influence Works?

Big Pharma, the “invisible world government”, drugs, malnutrition, stress, or even anal sex – how could all these stuff explain the origin of AIDS if someone 'turns off' critical thinking?

4 April 2017

3712

Garden Dedicated To People Living With HIV Opens In Canberra Australia

Garden Dedicated To People Living With HIV Opens In Canberra Australia

The Australian National Arboretum Canberra has opened a new 500–square metre AIDS Garden of Reflection – a garden dedicated to people living with HIV. Funds required to build a garden of $170,000, collected by The AIDS Action Council of Australia.

4 April 2017

3942

Injectable PrEP Trial: One Injection Every Eight Weeks

Injectable PrEP Trial: One Injection Every Eight Weeks

A large trial whether long-acting cabotegravir injected every eight weeks protects against HIV as well as daily oral Truvada among the high-risk participants has started at 45 sites in eight countries.

1...3 4 5 6